Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$50,000.00

Genetic analysis of a potential antidiabetic gut bacterium

FY 2017-18

Summary
The gut microbiome houses a dense population of bacteria that are essential for human health. Changes to the composition of the gut microbiota are linked to multiple diseases, including obesity and diabetes. A promising strategy to treat and prevent these chronic diseases is to manipulate target the bacteria that live in the gut. In this study, we will investigate the basic mechanisms of colonization by a potential antidiabetic bacterium, Akkermansia muciniphila. Obesity and diabetes are associated with a loss of Akkermansia compared to healthy individuals, and Akkermansia protects against obesity in mice. We will use modern genetic tools we developed to study how Akkermansia colonizes the gut and contributes to health. We will focus on how Akkermansia acquires its food source, the mucus lining of the intestinal tract, and how this contributes to colonization. To investigate why Akkermansia is less abundant in obese individuals, we will test bacteria obtained from a bank of patient samples for novel species that inhibit Akkermansia growth. With knowledge of how Akkermansia colonizes the gut and interacts with other bacteria, we will be in a better position to develop novel probiotic treatments for metabolic diseases.
Program
CIHR Fellowship
Location
North Carolina, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
376780
Name
Davey Lauren
Region
North Carolina
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Genetic analysis of a potential antidiabetic gut bacterium
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Akkermansia Muciniphila; Microbiome; Mutagenesis; Obesity; Tn-Seq
Abstract
The gut microbiome houses a dense population of bacteria that are essential for human health. Changes to the composition of the gut microbiota are linked to multiple diseases, including obesity and diabetes. A promising strategy to treat and prevent these chronic diseases is to manipulate target the bacteria that live in the gut. In this study, we will investigate the basic mechanisms of colonization by a potential antidiabetic bacterium, Akkermansia muciniphila. Obesity and diabetes are associated with a loss of Akkermansia compared to healthy individuals, and Akkermansia protects against obesity in mice. We will use modern genetic tools we developed to study how Akkermansia colonizes the gut and contributes to health. We will focus on how Akkermansia acquires its food source, the mucus lining of the intestinal tract, and how this contributes to colonization. To investigate why Akkermansia is less abundant in obese individuals, we will test bacteria obtained from a bank of patient samples for novel species that inhibit Akkermansia growth. With knowledge of how Akkermansia colonizes the gut and interacts with other bacteria, we will be in a better position to develop novel probiotic treatments for metabolic diseases.
Competitiondate
201711
Approvedterm2
1 yr 0 mth
Pinamesdelim
Davey, Lauren
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~
Direct Payment - $50,000 Grant (2017-18) | Canada Spends